Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 630

1.

Collocated observations of cloud condensation nuclei, particle size distributions, and chemical composition.

Schmale J, Henning S, Henzing B, Keskinen H, Sellegri K, Ovadnevaite J, Bougiatioti A, Kalivitis N, Stavroulas I, Jefferson A, Park M, Schlag P, Kristensson A, Iwamoto Y, Pringle K, Reddington C, Aalto P, Äijälä M, Baltensperger U, Bialek J, Birmili W, Bukowiecki N, Ehn M, Fjæraa AM, Fiebig M, Frank G, Fröhlich R, Frumau A, Furuya M, Hammer E, Heikkinen L, Herrmann E, Holzinger R, Hyono H, Kanakidou M, Kiendler-Scharr A, Kinouchi K, Kos G, Kulmala M, Mihalopoulos N, Motos G, Nenes A, O'Dowd C, Paramonov M, Petäjä T, Picard D, Poulain L, Prévôt AS, Slowik J, Sonntag A, Swietlicki E, Svenningsson B, Tsurumaru H, Wiedensohler A, Wittbom C, Ogren JA, Matsuki A, Yum SS, Myhre CL, Carslaw K, Stratmann F, Gysel M.

Sci Data. 2017 Mar 14;4:170003. doi: 10.1038/sdata.2017.3.

2.

C/EBPβ regulates homeostatic and oncogenic gastric cell proliferation.

Regalo G, Förster S, Resende C, Bauer B, Fleige B, Kemmner W, Schlag PM, Meyer TF, Machado JC, Leutz A.

J Mol Med (Berl). 2016 Dec;94(12):1385-1395. Epub 2016 Aug 13.

3.

SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.

Schmid F, Wang Q, Huska MR, Andrade-Navarro MA, Lemm M, Fichtner I, Dahlmann M, Kobelt D, Walther W, Smith J, Schlag PM, Stein U.

Oncogene. 2016 Nov 17;35(46):5942-5952. doi: 10.1038/onc.2015.451. Epub 2015 Dec 21.

PMID:
26686083
4.

Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.

Tanis E, Julié C, Emile JF, Mauer M, Nordlinger B, Aust D, Roth A, Lutz MP, Gruenberger T, Wrba F, Sorbye H, Bechstein W, Schlag P, Fisseler A, Ruers T.

Eur J Cancer. 2015 Nov;51(17):2708-17. doi: 10.1016/j.ejca.2015.08.014. Epub 2015 Sep 2.

PMID:
26342674
5.

Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in Klatskin tumor patients.

Lederer A, Herrmann P, Seehofer D, Dietel M, Pratschke J, Schlag P, Stein U.

Hepatology. 2015 Sep;62(3):841-50. doi: 10.1002/hep.27885. Epub 2015 Jun 26.

PMID:
25953673
6.

High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients.

Ilm K, Kemmner W, Osterland M, Burock S, Koch G, Herrmann P, Schlag PM, Stein U.

Mol Cancer. 2015 Feb 14;14:38. doi: 10.1186/s12943-015-0316-2.

7.

RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.

Dahlmann M, Okhrimenko A, Marcinkowski P, Osterland M, Herrmann P, Smith J, Heizmann CW, Schlag PM, Stein U.

Oncotarget. 2014 May 30;5(10):3220-33.

8.

The course of gastric cancer following surgery is associated with genetic variations of the interleukin-1 receptor antagonist and interleukin-1β.

van der Ploeg AH, Kumpf O, Seelow E, Almanza LC, Schlag PM, Schumann RR, Hamann L.

Gastric Cancer. 2015 Jan;18(1):77-83. doi: 10.1007/s10120-014-0349-z. Epub 2014 Feb 21.

PMID:
24557417
9.

Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector.

Kobelt D, Aumann J, Schmidt M, Wittig B, Fichtner I, Behrens D, Lemm M, Freundt G, Schlag PM, Walther W.

Mol Oncol. 2014 May;8(3):609-19. doi: 10.1016/j.molonc.2013.12.019. Epub 2014 Jan 18.

10.

Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983.

Tanis E, Nordlinger B, Mauer M, Sorbye H, van Coevorden F, Gruenberger T, Schlag PM, Punt CJ, Ledermann J, Ruers TJ.

Eur J Cancer. 2014 Mar;50(5):912-9. doi: 10.1016/j.ejca.2013.12.008. Epub 2014 Jan 7.

PMID:
24411080
11.

Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function.

Schirrmacher V, Fournier P, Schlag P.

Expert Rev Vaccines. 2014 Jan;13(1):117-30. doi: 10.1586/14760584.2014.854169. Review.

PMID:
24219122
12.

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Mauer M, Tanis E, Van Cutsem E, Scheithauer W, Gruenberger T; EORTC Gastro-Intestinal Tract Cancer Group.; Cancer Research UK.; Arbeitsgruppe Lebermetastasen und–tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO).; Australasian Gastro-Intestinal Trials Group (AGITG).; Fédération Francophone de Cancérologie Digestive (FFCD)..

Lancet Oncol. 2013 Nov;14(12):1208-15. doi: 10.1016/S1470-2045(13)70447-9. Epub 2013 Oct 11.

PMID:
24120480
13.

Current status of gene therapy for cancer.

Walther W, Schlag PM.

Curr Opin Oncol. 2013 Nov;25(6):659-64. Review.

PMID:
24100345
14.

Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer.

Juneja M, Ilm K, Schlag PM, Stein U.

Mol Oncol. 2013 Oct;7(5):929-43. doi: 10.1016/j.molonc.2013.05.003. Epub 2013 Jun 6.

15.

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial.

Gisslinger H, Gotic M, Holowiecki J, Penka M, Thiele J, Kvasnicka HM, Kralovics R, Petrides PE; ANAHYDRET Study Group..

Blood. 2013 Mar 7;121(10):1720-8. doi: 10.1182/blood-2012-07-443770. Epub 2013 Jan 11.

16.

HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: Gene gun is superior to jet injector in inducing CTL responses and protective immunity.

Nguyen-Hoai T, Kobelt D, Hohn O, Vu MD, Schlag PM, Dörken B, Norley S, Lipp M, Walther W, Pezzutto A, Westermann J.

Oncoimmunology. 2012 Dec 1;1(9):1537-1545.

17.

Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis.

Stein U, Burock S, Herrmann P, Wendler I, Niederstrasser M, Wernecke KD, Schlag PM.

PLoS One. 2012;7(11):e49249. doi: 10.1371/journal.pone.0049249. Epub 2012 Nov 14.

18.

Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer.

Nitsche U, Rosenberg R, Balmert A, Schuster T, Slotta-Huspenina J, Herrmann P, Bader FG, Friess H, Schlag PM, Stein U, Janssen KP.

Ann Surg. 2012 Nov;256(5):763-71; discussion 771. doi: 10.1097/SLA.0b013e318272de87.

PMID:
23095620
19.

Intratumoral dispersion, retention, systemic biodistribution, and clearance of a small-size tumor necrosis factor-α-expressing MIDGE vector after nonviral in vivo jet-injection gene transfer.

Galling N, Kobelt D, Aumann J, Schmidt M, Wittig B, Schlag PM, Walther W.

Hum Gene Ther Methods. 2012 Aug;23(4):264-70. doi: 10.1089/hgtb.2012.064. Epub 2012 Aug 27.

PMID:
22924532
20.

Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation.

Dahlmann M, Sack U, Herrmann P, Lemm M, Fichtner I, Schlag PM, Stein U.

Oncotarget. 2012 Aug;3(8):783-97.

Supplemental Content

Loading ...
Support Center